Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications - Wikidata - wikimedia - TriplyDB

Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications

Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications

http://www.wikidata.org/entity/Q24645440

about

Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement Psychostimulants and cognition: a continuum of behavioral and cognitive activation Future pharmacological treatments for substance use disorders The dopamine theory of addiction: 40 years of highs and lows Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants Modafinil for schizophrenia Efficacy of Psychostimulant Drugs for Cocaine Dependence Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT Nonhuman primate positron emission tomography neuroimaging in drug abuse research Dopamine transporter-related effects of modafinil in rhesus monkeys.Modafinil blocks reinstatement of extinguished opiate-seeking in rats: mediation by a glutamate mechanism Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse A practical guide to the therapy of narcolepsy and hypersomnia syndromes Neuroimaging and drug taking in primates Pharmacotherapy for stimulant-related disorders Pharmacotherapy of amphetamine-type stimulant dependence: an update Agonist replacement for stimulant dependence: a review of clinical research The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.Differential effects of environment-induced changes in body temperature on modafinil's actions against methamphetamine-induced striatal toxicity in mice The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction Acute effects of modafinil on brain resting state networks in young healthy subjects Cognitive Test Anxiety and Cognitive Enhancement: The Influence of Students’ Worries on Their Use of Performance-Enhancing Drugs History of narcolepsy at Stanford University.Monoamine transporter inhibitors and substrates as treatments for stimulant abuse Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee.Modulatory effects of modafinil on neural circuits regulating emotion and cognition.What influences clinicians' decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ).Positron Emission Tomography (PET) and Graphical Kinetic Data Analysis of the Dopamine Neurotransmitter System: An Exercise for an Undergraduate Laboratory Course Neuroimaging the Effectiveness of Substance Use Disorder Treatments.Cognitive enhancement as a pharmacotherapy target for stimulant addiction Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157.Modafinil does not serve as a reinforcer in cocaine abusers Action of modafinil--increased motivation via the dopamine transporter inhibition and D1 receptors?Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives.

P2860

Q21129426-49778848-0A90-43B7-9686-F1C0B2747661 Q21203313-46D3A20B-6A9A-42A4-80A5-A0BF154A3FC6 Q21558807-AAAF34AA-2AF0-4866-9D8C-4AE08EF9CC61 Q22242285-B47C8205-F356-43B3-947D-FA3430AFCD20 Q22242633-97A80147-2F69-468D-BA20-DDEC3EB0CE64 Q22251015-EB24CF37-953B-451C-814C-046F3FABCC41 Q22251215-4EF2B332-A911-4556-BE05-841FE267E06B Q24235809-EC9276B0-39E0-4131-926A-A35D12224079 Q24239994-49125B5A-FB13-430F-9C88-DC2D52D9AD6B Q24602466-293E7EC5-FD16-4F65-93D3-B66551EBC259 Q24607038-54202FEF-C7DB-42A6-86FC-EE18C9C7BB22 Q24608414-1CF9C8B5-573B-4A1C-9CDF-DB88A778133D Q24608557-48036D29-0703-460E-976B-6704B5AB585D Q24615244-7611EE20-88D9-4806-9992-551D97B1284E Q24621917-96294BE4-4297-4238-A74C-91244929B036 Q24623713-340273D5-B70B-40C3-B833-5C4E9514FC35 Q24631230-57DBCA81-C266-416B-83C1-ECE169E4FA02 Q26829186-1BDA154E-04DB-44AF-94BE-84D08C06C893 Q26991936-83909431-BF64-453C-AF66-7855D2AF1F03 Q27014854-1D2E7801-0F64-4768-A38D-DBFA3D0399BD Q27024180-DD5C96CE-0EB6-4A40-8CA8-BC3F3DC5C896 Q28085253-A64B156F-DDF6-4A6E-A102-6B75BB2F9A97 Q28397225-3D952315-A2B7-451F-99B2-B3291C6B8CF4 Q28477546-21589B10-8FE2-4FEB-95B3-AFCC89D3942F Q28484231-E1D076FD-AE80-4D63-BA38-430A421099A3 Q28486981-6A90E6A4-A392-4938-9F8B-8980BA9715C0 Q28534885-C383B46A-BE82-40EC-9D85-BF2DDF807EF1 Q29396346-94058B7E-8848-48CC-BE53-120BB2E65170 Q30362536-36941821-8B31-45F2-8820-9CED7AEBBC2D Q30413718-B4E8F0FE-D547-4019-A429-F1DA4FDB69BF Q30434422-6585ED50-7403-4374-9CC3-4B3A45F56876 Q30497780-D57FA0F6-0EA1-4754-9FBE-C56144F1DFB8 Q30596479-0BDEE8C7-D576-46F4-AAC2-4ECBDBD724DA Q30791718-78492126-F0D1-4930-B2E3-6324DCD1958F Q31096451-CCDE728A-9738-4296-9C1E-14A4AE3CD1E4 Q33599983-42C58ACD-1FBD-4E6D-B6EE-D2355A4BC1B2 Q33708210-71A57545-CBE9-4964-9CA2-85B4F1CEB591 Q33744007-B64EB93C-4B51-4ECB-B3D7-A8D79E13FB6A Q33771079-786E1F84-2730-4572-94A1-F5A024DF04D6 Q33821312-2FF6ECBC-45C0-4121-BEE0-0AC9BE8F652B

P2860

Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications

http://www.wikidata.org/entity/Q24645440

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effects of modafinil on dopami ...... n brain: clinical implications

@ast

Effects of modafinil on dopami ...... n brain: clinical implications

@en

Effects of modafinil on dopami ...... n brain: clinical implications

@nl

type

label

Effects of modafinil on dopami ...... n brain: clinical implications

@ast

Effects of modafinil on dopami ...... n brain: clinical implications

@en

Effects of modafinil on dopami ...... n brain: clinical implications

@nl

prefLabel

Effects of modafinil on dopami ...... n brain: clinical implications

@ast

Effects of modafinil on dopami ...... n brain: clinical implications

@en

Effects of modafinil on dopami ...... n brain: clinical implications

@nl

P1433

Q24645440-09E21BEE-26FB-416E-A442-0DC5F5D6C060

P1476

Q24645440-CC7BA961-0231-4BF2-9AC5-65EBE366BC6D

P2093

Q24645440-06E2E5F6-84CF-4798-835A-54F4A2DCBCF5

Q24645440-0F68C255-C362-401F-965D-B9B7CCE65544

Q24645440-239686AB-8E42-46C8-B594-EC841FCB422D

Q24645440-257BA6F6-F1FD-4AA3-B336-DA9262EB68CE

Q24645440-2E5B67AD-5121-487A-8044-DBD5B51A292A

Q24645440-3760D07A-0FDD-4049-B2DB-1A28B4CCA2DA

Q24645440-686C826D-1676-45DF-8D5D-EAADF25226F4

Q24645440-70AFCC8D-546D-4CFE-A0AA-30539E34241D

Q24645440-7A70F9A3-4466-4D39-8B8B-BB8CCA4AE8E6

Q24645440-7E1580D6-4DCA-49BF-9B2A-68E206B5D334

P2860

Q24645440-01BF8FCE-4B7F-4CF5-B9E1-A62DFEB963CC

Q24645440-062BE2F1-0A19-4FC4-8451-973B0BD32F44

Q24645440-23326599-7E05-4085-9094-A3E4C2529095

Q24645440-27A69212-329A-42FB-8D0C-F8909E13F322

Q24645440-2A6F4AED-5B19-404E-BECB-DF4B1723629B

Q24645440-2C481C99-D4F0-46E9-8953-C5311BEC12A6

Q24645440-427B877F-D719-43EB-ABF7-E5000D750B54

Q24645440-4F471D3D-4018-4B15-8230-B0BF658D9F96

Q24645440-4F67B5C6-CB21-4F8D-8F31-4A7AD6A19A0D

Q24645440-5710A226-0AC7-48A7-97D7-9B87ABE964B2

P304

Q24645440-98E1B301-6A00-40E4-BAA0-63DFEBB5EE5F

P31

Q24645440-091492AD-1227-4613-ADD5-AF6B3F03B1FB

P3181

Q24645440-345E49A2-2417-4779-A29E-BADD950B1375

P356

Q24645440-3909FC2F-3F3A-4C6E-B5CB-88249A4DE106

P407

Q24645440-FD5756D6-D5D4-4D63-9C0A-0C96A2159672

P433

Q24645440-BD9A225D-7671-479E-AF4D-D07350D19761

P478

Q24645440-91F4B823-39AE-43E1-98C7-71B063C02B26

P577

Q24645440-72485720-8DFB-4A57-867D-410591AD13E4

P5875

Q24645440-056A6306-D094-4CE0-A38F-01B934D4B5C5

P698

Q24645440-0C08DB38-20ED-4CE4-A14B-D2A37487A182

P921

Q24645440-198436D9-471B-4F22-8192-0B9D9CBB99D3

Q24645440-6E481113-F92A-45BB-BE84-5F5FB8D8BDDF

Q24645440-c2a016e4-842a-4047-a00e-b74402fd03f9

P932

Q24645440-46311B63-1AE5-4092-A04E-5857EB5C9701

P3181

P356

P1433

Journal of the American Medical Association

P1476

Effects of modafinil on dopami ...... n brain: clinical implications

@en

P2093

Barbara Hubbard

http://www.w3.org/2001/XMLSchema#string

Christopher Wong

http://www.w3.org/2001/XMLSchema#string

Colleen Shea

http://www.w3.org/2001/XMLSchema#string

David Alexoff

http://www.w3.org/2001/XMLSchema#string

Donald Warner

http://www.w3.org/2001/XMLSchema#string

Frank Telang

http://www.w3.org/2001/XMLSchema#string

Gene-Jack Wang

http://www.w3.org/2001/XMLSchema#string

Jacob M Hooker

http://www.w3.org/2001/XMLSchema#string

Jean Logan

http://www.w3.org/2001/XMLSchema#string

Joanna S Fowler

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study

Dopaminergic role in stimulant-induced wakefulness.

Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy.

THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD.

Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats.

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Hypothalamic arousal regions are activated during modafinil-induced wakefulness.

Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats.

P304

1148-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2649667

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.2009.351

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

301

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24207541

http://www.w3.org/2001/XMLSchema#string

P698

19293415

http://www.w3.org/2001/XMLSchema#string

P921

P932

2696807

http://www.w3.org/2001/XMLSchema#string